Jason E. Drury

发表

Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor

M. Meagher, T. Lockey, Alicia D. Powers, 2020, Molecular therapy. Methods & clinical development.

Structure and catalytic mechanism of human steroid 5β-reductase (AKR1D1)

D. Christianson, L. Costanzo, T. Penning, 2009, Molecular and Cellular Endocrinology.

Inhibition of Human Steroid 5β-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex*

D. Christianson, T. Penning, L. D. Di Costanzo, 2009, The Journal of Biological Chemistry.

Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)

T. Penning, Mo Chen, Jason E. Drury, 2011, Steroids.

Characterization of Disease-related 5β-Reductase (AKR1D1) Mutations Reveals Their Potential to Cause Bile Acid Deficiency*

T. Penning, R. Mindnich, Jason E. Drury, 2010, The Journal of Biological Chemistry.

The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function.

T. Penning, R. Mindnich, Jason E. Drury, 2011, Chemico-biological interactions.

Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector

C. Morton, A. Davidoff, A. Nathwani, 2016, Molecular therapy. Methods & clinical development.

Conversion of Human Steroid 5β-Reductase (AKR1D1) into 3β-Hydroxysteroid Dehydrogenase by Single Point Mutation E120H

Trevor M Penning, D. Christianson, T. Penning, 2012, The Journal of Biological Chemistry.

Permeation and Activation of the M2 Ion Channel of Influenza A Virus*

R. Lamb, S. Frings, L. Pinto, 2000, The Journal of Biological Chemistry.

Catalytic Properties of Intramembrane Aspartyl Protease Substrate Hydrolysis Evaluated Using a FRET Peptide Cleavage Assay.

Sibel Kalyoncu, S. Hill, J. Johnson, 2015, ACS chemical biology.

Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Trevor M Penning, T. Penning, Jason E Drury, 2007, Archives of biochemistry and biophysics.

Stable carbon isotope ratio profiling of illicit testosterone preparations--domestic and international seizures.

A. Cawley, N. Hasick, C. Goebel, 2014, Drug testing and analysis.

Crystal Structure of Human Liver Δ4-3-Ketosteroid 5β-Reductase (AKR1D1) and Implications for Substrate Binding and Catalysis*♦

D. Christianson, T. Penning, L. D. Di Costanzo, 2008, Journal of Biological Chemistry.

Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants.

Yoshiyuki Suzuki, K. Higaki, E. Nanba, 2014, ACS chemical biology.

Conversion of scFv peptide-binding specificity for crystal chaperone development.

J. Maynard, J. Culver, Jennifer C. Pai, 2011, Protein engineering, design & selection : PEDS.

Structure–function relationship of the M2 ion channel of influenza A virus

R. Lamb, S. Frings, L. Pinto, 2001 .

Crystal Structure of Human Liver 4-3-Ketosteroid 5-Reductase ( AKR 1 D 1 ) and Implications for Substrate Binding and Catalysis *

D. Christianson, L. Costanzo, Jason E. Drury, 2008 .